Archives of Clinical Infectious Diseases

Published by: Kowsar

Prevalence of Ceftriaxon-Sensitive Pneumococci Infection and Use of E- Test for Patients Admitted to Ghaem and Imam Reza Hospitals During a Two-Year Period

Ashraf Tavanaee Sani 1 , * , Maryam Mojtabavi 1 and Kiarash Ghazvini 2
Authors Information
1 Department of Infectious Diseases, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Department of Microbiology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: July 9, 2012, 7 (3); 85-7
  • Published Online: July 2, 2012
  • Article Type: Research Article
  • Received: April 6, 2012
  • Revised: April 20, 2012
  • Accepted: May 3, 2012
  • DOI: 10.5812/archcid.14470

To Cite: Tavanaee Sani A, Mojtabavi M, Ghazvini K. Prevalence of Ceftriaxon-Sensitive Pneumococci Infection and Use of E- Test for Patients Admitted to Ghaem and Imam Reza Hospitals During a Two-Year Period, Arch Clin Infect Dis. 2012 ; 7(3):85-7. doi: 10.5812/archcid.14470.

Copyright © 2012, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Musher DM. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 2010; : 2635
  • 2. Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001; 32 Suppl 2-93[DOI][PubMed]
  • 3. Swenson JM, Hill BC, Thornsberry C. Screening <italic>Pneumococci</italic> for Penicillin resistance. J Clin Microbiol. 1986; 24(5): 749-52[PubMed]
  • 4. Jacobs MR, Koornhof HJ, Robins-Browne RM, Stevenson CM, Vermaak ZA, Freiman I, et al. Emergence of multiply resistant <italic>Pneumococci</italic>. N Engl J Med. 1978; 299(14): 735-40[DOI][PubMed]
  • 5. Ward JI, Moellering RC, Jr. Susceptibility of <italic>Pneumococci</italic> to 14 beta-lactam agents: comparison of strains resistant, intermediate-resistant, and susceptible to penicillin. Antimicrob Agents Chemother. 1981; 20(2): 204-7[PubMed]
  • 6. Li J, Zhang Y, Chen Y, Hao F. E test for studying in vitro activity of seven antimicrobial agents against Penicillin-susceptible and Penicillin-resistant <italic>Pneumococci</italic>. Chin Med J (Engl). 2000; 113(7): 628-31[PubMed]
  • 7. Linares J, Pallares R, Alonso T, Perez JL, Ayats J, Gudiol F, et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis. 1992; 15(1): 99-105[PubMed]
  • 8. Desa MNM, Lin TK, Yasin RMd, Parasakthi N. Penicillin susceptibility and molecular characteristics of clinical isolates of <italic>Streptococcus Pneumoniae</italic> at the University of Malaya Medical Center, Kuala Lumpur, Malaysia. Int J Infect Dis. 2003; 7(3): 190-197
  • 9. Johnson DM, Stilwell MG, Fritsche TR, Jones RN. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003). Diagn Microbiol Infect Dis. 2006; 56(1): 69-74[DOI][PubMed]
  • 10. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA. 1994; 271(23): 1831-5[PubMed]
  • 11. Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother. 2001; 45(6): 1721-9[DOI][PubMed]
  • 12. Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005. Clin Infect Dis. 2009; 48(3)-33[DOI][PubMed]
  • 13. Doern GV. Manual of clinical microbiology. 1995; : 1342–9
  • 14. Dowson CG, Johnson AP, Cercenado E, George RC. Genetics of oxacillin resistance in clinical isolates of Streptococcus pneumoniae that are oxacillin resistant and penicillin susceptible. Antimicrob Agents Chemother. 1994; 38(1): 49-53[PubMed]
  • 15. Aspa J, Rajas O, de Castro FR. Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia. Expert Opin Pharmacother. 2008; 9(2): 229-41[DOI][PubMed]
  • 16. Van Bambeke F, Reinert RR, Appelbaum PC, Tulkens PM, Peetermans WE. Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options. Drugs. 2007; 67(16): 2355-82[PubMed]
  • 17. Chiou CC, Yu VL. Severe pneumococcal pneumonia: new strategies for management. Curr Opin Crit Care. 2006; 12(5): 470-6[DOI][PubMed]
  • 18. Chiu CH, Su LH, Huang YC, Lai JC, Chen HL, Wu TL, et al. Increasing ceftriaxone resistance and multiple alterations of penicillin-binding proteins among penicillin-resistant Streptococcus pneumoniae isolates in Taiwan. Antimicrob Agents Chemother. 2007; 51(9): 3404-6[DOI][PubMed]
  • 19. Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother. 2004; 48(6): 2101-7[DOI][PubMed]
  • 20. Hsu KK, Shea KM, Stevenson AE, Pelton SI. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007. Pediatr Infect Dis J. 2010; 29(4): 289-93[DOI][PubMed]
  • 21. Wayne PA. Performance standards for antimicrobial susceptibility testing, sixteenth informational supplement. Clin Lab Stand Inst. 2006; 26(3)
  • 22. Vanderkooi OG, McConnell A, Church DL, Kellner JD. Antimicrobial susceptibility of invasive and lower respiratory tract isolates of Streptococcus pneumoniae, 1998 to 2007. Can J Infect Dis Med Microbiol. 2009; 20(4)-44[PubMed]
  • 23. Su LH, Wu TL, Kuo AJ, Chia JH, Chiu CH. Antimicrobial susceptibility of Streptococcus pneumoniae at a university hospital in Taiwan, 2000-07: impact of modified non-meningeal penicillin breakpoints in CLSI M100-S18. J Antimicrob Chemother. 2009; 64(2): 336-42[DOI][PubMed]
  • 24. Twum-Danso K, Al-Mazrou AM, Kambal AM, Al-Zamil FA. Penicillin resistance in serogroups/serotypes of Streptococcus pneumoniae causing invasive infections in Central Saudi Arabia. Saudi Med J. 2003; 24(11): 1210-3[PubMed]
  • 25. Mojtabavi M, Naderi HR, Tavanaee Sani A, Bagheri M, Ghazvini K. First Report of a Case of Pneumococcal Meningitis Which Did Not Respond to the Ceftriaxone Therapy despite the Isolated Organism Being Sensitive to This Antibiotic In Vitro. Case Rep Pulmonol. 2011; 2011: 485952[DOI][PubMed]
  • 26. Karlowsky JA, Jones ME, Draghi DC, Sahm DF. Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime. Antimicrob Agents Chemother. 2003; 47(10): 3155-60[PubMed]
  • 27. Skull SA, Leach AJ, Currie BJ. Streptococcus pneumoniae carriage and penicillin/ceftriaxone resistance in hospitalised children in Darwin. Aust N Z J Med. 1996; 26(3): 391-5[PubMed]
  • 28. Yao KH, Wang LB, Zhao GM, Zheng YJ, Deng L, Zhao RZ, et al. [Surveillance of antibiotic resistance of Streptococcus pneumoniae isolated from hospitalized patients with pneumonia in four children's hospitals in China]. Zhongguo Dang Dai Er Ke Za Zhi. 2008; 10(3): 275-9[PubMed]
  • 29. Coman G, Petraru E, Filip R, Dahorea C, Butnaru F. Ceftriaxone resistance in <italic>Streptococcus Pneumoniae</italic> isolated from pediatric infections. J Prevent Med. 2002; 10(4): 49-55
  • 30. Mostafavizade K,, Khourvash F, Abousaeidi H, Fasihi Dastjerdi M, Mobasherizadeh S, Izadi M, et al. Determination of Streptococcus pneumoniae resistant to penicillin and ceftriaxone by E-test method. Kowsar Medical J. 2008; 12(4): 325-30
  • 31. Varman M. Pediatric Pneumococcal Infections Medication.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments